Mindmed to present at the jefferies london healthcare conference

New york, nov. 12, 2021 /prnewswire/ -- mind medicine (mindmed) inc. (nasdaq: mnmd), (neo: mmed), (de: mmq) (the "company"), a leading biotech company developing psychedelic-inspired therapies, is pleased to announce that its ceo, robert barrow, will be speaking at jefferies 2021 london healthcare conference, taking place on november 16-19. management will be available during the conference for in-person and virtual one-on-one meetings.
MNMD Ratings Summary
MNMD Quant Ranking